About Us
PORIB is a Health Evaluation, Market Access, and Real-World Evidence (RWE)/ Health Outcomes Research consultancy, founded in 2004, which provides its services to the Pharmaceutical and Health Technology Industry, Healthcare Administrations, Universities, Patient Organizations, and Healthcare Professionals
- PORIB provides a complete range of strategically focused services: Economic Evaluation, Pricing and Reimbursement, Market Access, RWE/Health Outcomes Research, Evidence and Scientific Writing, Health Management, Advisory Boards with Decision Makers, Biostatistics and Training.
- PORIB has a team of skilled and multidisciplinary specialists from different backgrounds: Pharmacy, Economics, Psychology, Statistics, Biology, and Information Sciences.
- PORIB collaborates with numerous companies within the healthcare sector to demonstrate the value of health interventions, through the dissemination and publication of articles and scientific communications in different therapeutic areas.
PORIB team
Miguel Ángel Casado
Managing Director
OIRUB
María Yébenes
RWE Manager
PORIB
Itziar Oyagüez
Associate Director
PORIB
Araceli Casado
Senior RWE Specialist
porib
María Echave
Manager in Scientific Evidence
PORIB
Manuel Gómez-Barrera
Manager in Health Economics and Biostatistics
Raquel Domínguez
Manager in Health Economics and Modelling
Ana Murillo
Communication and Quality Manager
María Mareque
Senior Health Economics and Modelling Specialist
María Presa
Senior Health Economics Specialist and Project Management
Nataly Espinoza
Health Economics Specialist
PORIB
Laura Salinas
Health Economics Specialist
PORIB
Alberto de la Cuadra
Health Economics and Biostatistics Specialist
Sofía de Pedro
Health Economics Specialist
PORIB
Mireya Robles
Health Economics Specialist
PORIB
Paula Castro
Health Economics Specialist
PORIB
Rocío González
Health Economics Specialist
PORIB
Alexander Vázquez
Junior Health Economics Specialist
PORIB
Mission-Values
The mission of PORIB is the coordination and development of Health Evaluation, Market Access, and Real-World Evidence (RWE)/ Health Outcomes Research activities, with the aim of:
- Generating clinical, economic, humanistic, and social evidence to demonstrate the value, quality, safety, effectiveness and therapeutic utility of innovative medicines and health interventions.
- Demonstrating efficiency of medicines, technologies, interventions, and health services.
The most important values of PORIB are based on its corporate identity:
- Quality, excellence, innovation, transparency, and integrity.
- Absolute respect for confidentiality.
- Experienced and skilled team.
- Teamwork in coordination with our clients and with multidisciplinary teams: clinicians, pharmacists, nurses, epidemiologists, statisticians, economists, healthcare payers, psychologists, sociologists, and information sciences specialists.
